Clinical Trial Network For Antibiotics Included In President’s FY 2016 Budget
This article was originally published in The Pink Sheet Daily
Executive Summary
$1.2 billion budget request to combat antibiotic resistance includes $650 million for development of antibacterials; supports development of new approval pathway.
You may also be interested in...
Top US FDA Drug Policy Leader Leaving For White House Detail
Grail Sipes, CDER deputy center director for regulatory policy, will move to the Executive Office of the President next month.
FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes
Stakeholders suggest a variety of USPTO and FDA actions that could help ensure patents do not improperly delay generic and biosimilar competition.
FDA Urged To Collaborate With USPTO On Orange Book Listings, Eliminate Patent Use Codes
Stakeholders suggest a variety of USPTO and FDA actions that could help ensure patents do not improperly delay generic and biosimilar competition.